Evidence map›Paper›PMID 31929868›Full record

ArticleClinics and practice2019

Severe nephritis as initial sign of Waldenström's macroglobulinemia.

Thomas Knoop, Kristin Kampevold Larsen, Friedemann Leh, Anette Lodvir Hemsing, Ingrid Anna Teigen, Håkon Reikvam

Open access · goldAbstract read
In one paragraph

Article in Clinics and practice, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 75% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Thomas KnoopDepartment of Medicine, Haukeland University Hospital.
Kristin Kampevold LarsenDepartment of Pathology, Haukeland University Hospital.
Friedemann LehDepartment of Pathology, Haukeland University Hospital.
Anette Lodvir HemsingDepartment of Medicine, Haukeland University Hospital.
Ingrid Anna TeigenDepartment of Pharmacology, Haukeland University Hospital.
Håkon ReikvamDepartment of Medicine, Haukeland University Hospital.
Haukeland University Hospital · NOUniversity of Bergen · NO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Waldenström's macroglobulinemia (WM), characterized with monoclonal immunoglobulins of type M and lymphoplasmacytic lymphoma, is a rare clonal Bcell disorder. WM usually present as an indolent lymphoma, and renal involvement is, in contrast to multiple myeloma, very rarely seen. We present a patient presenting with severe nephritis and nephrotic range proteinuria of more than 9 g/day as initial manifestations of WM. Furthermore, we discuss diagnostic and therapeutic approaches for this rare manifestation of the disease, in the light of recent research and treatment recommendations.

Indexed as

hypertensionNephriteproteinuriaWaldenström’s macroglobulinemia

Identifiers

PMID31929868
PMCPMC6945070
OpenAlexW2995454090

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.